Molecular Diagnostics | EBV Qualitative by PCR, BAL

UWHC Lab Test Details
Test NameEBV Qualitative by PCR, BAL
Test Code(s)HCEBVBAL
CPT Code(s)87798
MethodologyReal-Time PCR
Clinical Information

Detect Epstein-Barr Virus (EBV) in bronchoalveolar lavage specimens.

Days PerformedMon-Fri.
In-Lab Turnaround Time2 - 3 days.
Stat In-Lab Turnaround TimeNot available stat.
Collection Requirements
Patient Preparation

Testing is performed Monday-Friday in batched runs. Specimens received by the Molecular Diagnostic lab by 8:30am will be run same day. If received after 8:30am it will be held to following day.

SpecimenBronchoalveolar lavage (BAL)
Collection Container
Collection ContainerSterile screw cap container
Collection Instructions

10-50 mL of lavage specimen is recommended.

Collection Volume50 mL
Pediatric Collection Volume12 mL
Specimen Processing Requirements
Stability
Stability Ambient

72 hours

Stability Refrigerated

72 hours

Stability Frozen

30 days

Sample AnalyzedBronchoalveolar lavage (BAL) fluid
Testing Volume3 mL
Pediatric Testing Volume1.2 mL
Specimen Transport

Transport specimen to Laboratory immediately. Transport fluid on coolant pack.

Unacceptable Criteria

LIMIT: One specimen every 48 hours.

Interpretation
Expected Results

Not detected

 

Detection of low levels of EBV in specimens containing leukocytes is not unexpected, due to the ubiquitous nature of EBV infection in the population.

Test Limitations

A "Not detected" result may be the result of PCR inhibitors, virus levels below the level of detection of this test, or virus diluted in a large sampling volume. Virus quantitation is not possible due to the nature of the specimen.

 

Inadequate specimen collection, processing and storage may invalidate test results. This test should not be used as the only criterion to form a clinical conclusion; instead, results should be correlated with other test results, patient symptoms and clinical presentation.

Additional Information

A "Detected" result in BAL specimens indicates the presence of EBV DNA. A result of "Not Detected" in BAL specimens does not rule out the presence of EBV DNA or the absence of infection.

 

False negative results may be due to the suppression of viral replication to levels below the detection threshold, insufficient specimen collection volumes, high dilution volumes, or to inhibitory substances that may be present in the specimen.

 

DNA sequence polymorphisms in EBV strains may results in underestimation of viral levels. The presence of variations in EBV DNA sequences are monitored in the real-time PCR assay. This assay does not genotype the virus, and consequently does not provide any information with regard to EBV drug resistance.

 

The performance characteristics of this test were validated by UWHC Clinical Laboratories. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test; however, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The UWHC Clinical Laboratories is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing.